Shaping of the Microenvironment in Colonic Pre-Cancer by Epithelia and Microbiota
Project Number1U54CA274367-01
Contact PI/Project LeaderSHRUBSOLE, MARTHA J. Other PIs
Awardee OrganizationVANDERBILT UNIVERSITY MEDICAL CENTER
Description
Abstract Text
The Vanderbilt TBEL Center assembles a multi-disciplinary team of field-specific experts to collaboratively
investigate the basic and translational pathways of colonic pre-cancer progression. Our foundational work on
two subtypes of colonic pre-cancers, adenomas (ADs) and sessile serrated lesions (SSLs), depicts the early
origins of tumorigenesis that are shaped by modulation of the immune microenvironment via neoplastic cells and
the microbiota. We have shown that SSLs originate from gastric metaplasia arising from the mucosal surface in
a cytotoxic immune microenvironment, whereas ADs arise from stem cell-derived WNT activation at the crypt
base. In this center, we will extend our investigation of specific biological mechanisms towards the developmental
trajectories of these pre-malignant lesions into progression or indolence. Basic Project 1 investigates the
contribution of neutrophil-AD crosstalk, largely via dipeptidase 1 (DPEP1) both at the cell surface and released
in small extracellular vesicles, in the course of AD progression. Translational Project 2 investigates, in human
prospective studies, the association of pks+ Escherichia coli that induces genotoxic stress with pre-cancer
progression, as well as colon epithelial cell and mucosa mechanisms that may contribute to a polyp-promoting
microenvironment. Basic Project 3 investigates acquisition of stemness in modulating antigen presentation to
cytotoxic T cells in the context of co-evolution between neoplastic cells and the immune system. Joint analysis
of common colorectal pre-cancer tissues will facilitate an ongoing process of iteration and integration across all
projects. Our TBEL Center offers a complementary blend, from reductionist and systems biology approaches, to
investigate critical factors involved in the progression of pre-cancerous tumors of the colon to CRC. The work
will utilize cutting-edge technologies on human tissues, including single-cell and spatial transcriptomics, small
extracellular vesicle profiling, multiplex imaging, longitudinal data analysis, and next-generation computational
algorithms. In addition, substantial human polyp resources previously established by the Vanderbilt GI
Specialized Programs of Research Excellence and the NCI Moonshot Human Tumor Atlas Network will be
leveraged by the same team of investigators in the TBEL Center. In addition, an innovative co-culture system
will be employed by each project, where polarizing pre-cancer organoids can be co-cultured with key
microenvironment elements exposed to neoplastic cells from the luminal or basal side. This work will inform the
modeling of tumor development trajectories and identify mechanisms of progression that will enable
improvements in risk stratification, precision prevention, and interception for individuals with colorectal pre-
cancers.
Public Health Relevance Statement
PROJECT NARRATIVE: Overall
Understanding how and which colorectal pre-cancers have the potential to progress to cancer will enable
improvements in risk stratification, precision prevention, and interception for individuals with colorectal pre-
cancers to prevent colorectal cancer deaths. This research center will seek to identify microbial, stem cell, and
cell-cell communication mechanisms that will inform which pre-malignant lesions progress and which will
remain indolent.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAntigen PresentationAtlasesBasic ScienceBig Bang CosmologyBindingBiologicalBiological ModelsBiological ProcessBiological SciencesBiometryCancer BiologyCancer EtiologyCarcinomaCell CommunicationCell LineCell surfaceCellsCellular biologyCessation of lifeChemopreventionClinical DataCoculture TechniquesColonColonic NeoplasmsColonoscopyColorectalColorectal AdenomaComputational BiologyComputational algorithmCytotoxic T-LymphocytesDataData AnalysesDetectionDevelopmentDipeptidasesDipeptidesDisease modelElementsEpidemiologyEpithelialEpithelial CellsEscherichia coliEvolutionExposure toFoundationsGastric MetaplasiaGenerationsGeneticGenotoxic StressGoalsHealth systemHumanImmuneImmune systemImmunofluorescence ImmunologicIndividualIndolentInterceptInvestigationJointsKnowledgeLeadLesionLongitudinal cohortMalignant NeoplasmsManuscriptsMicrobiologyModelingMolecularMucous MembraneNatureOrganoidsPathologyPathway interactionsPerforationPolypectomyPolypsPreventiveProcessProspective StudiesProteinsReportingResearchResearch PersonnelResearch Project GrantsResourcesRiskSeminalShapesSideSpecialized Program of Research ExcellenceSurfaceSystemSystems BiologyTechnologyTestingTissuesTranslational ResearchWomanWorkadenomabasecolon carcinogenesiscolorectal cancer preventioncost effectivecytotoxicdesignexosomeextracellular vesicleshigh riskhuman datahuman tissueimmunoregulationin vitro Modelin vivo Modelindividualized preventioninnovationiterative designmenmicrobialmicrobiotamolecular phenotypemultidisciplinarymultiplexed imagingneoplastic cellneutrophilnext generationnovelpolyketide synthasepremalignantpressurepreventprogramsprotein biomarkersrisk stratificationsingle-cell RNA sequencingstem cellsstemnesstranscriptomicstumortumor heterogeneitytumor microenvironmenttumor-immune system interactionstumorigenesis
No Sub Projects information available for 1U54CA274367-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U54CA274367-01
Patents
No Patents information available for 1U54CA274367-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U54CA274367-01
Clinical Studies
No Clinical Studies information available for 1U54CA274367-01
News and More
Related News Releases
No news release information available for 1U54CA274367-01
History
No Historical information available for 1U54CA274367-01
Similar Projects
No Similar Projects information available for 1U54CA274367-01